Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 4:52 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1849–1872 of 3,077 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Intracranial Vascular Disorders Clear all

Conditions: Stroke, Upper Limb Deficits
Interventions: Vagus Nerve Stimulation (VNS); Device
Lead sponsor: MicroTransponder Inc.; Industry
Eligibility: 30 Years to 80 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2022
U.S. locations: 3
States / cities: Minneapolis, Minnesota • Dallas, Texas • Houston, Texas

Conditions: Stroke
Interventions: tDCS: noninvasive brain stimulation, Constraint induced movement therapy (CIMT), Sham tDCS: placebo noninvasive brain stimulation; Procedure · Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 21 Years and older
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cardiovascular Disease
Interventions: AZD3366, Placebo, Ticagrelor, acetylsalicylic acid (ASA); Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 103 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Glendale, California

Conditions: Stroke, Ischemic, Stroke Hemorrhagic, Fever, Seizures, Metabolic Encephalopathy
Interventions: Transnasal Thermal Regulating Device; Device
Lead sponsor: CoolTech LLC; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • Houston, Texas

Conditions: Upper Extremity Paresis
Interventions: transcranial direct current stimulation; Device
Lead sponsor: University of the Sciences in Philadelphia; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Stroke
Interventions: Word Retrieval Treatments for Aphasia; Behavioral
Lead sponsor: Old Dominion University; Other
Eligibility: 21 Years to 90 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Intracerebral Hemorrhage
Interventions: Pioglitazone, Placebo Control; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 80 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Heart Diseases
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 21 Years to 95 Years
Enrollment: 5,302 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2004
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Chronic Kidney Diseases, Heart Attack, Stroke, Ischemic
Interventions: Ticagrelor 90mg, Clopidogrel 75mg, Aspirin 81 mg; Drug
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 91 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 2
States / cities: Little Rock, Arkansas

Conditions: Stroke, Cerebrovascular Stroke, Intracerebral Hemorrhage
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 6,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Stroke
Interventions: tenecteplase, tissue plasminogen activator, tPA; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 9
States / cities: San Diego, California • Englewood, Colorado • Baltimore, Maryland + 5 more

Conditions: Stroke, Stroke, Acute, Cerebrovascular Accident, Cerebrovascular Accident, Acute
Interventions: Ekso gait training, Standard physical therapy; Device · Procedure
Lead sponsor: Sunnyview Rehabilitation Hospital; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Schenectady, New York

Conditions: Chronic Post-stroke Headache
Interventions: Active rTMS and exercise, Sham rTMS+Exercise; Device · Combination Product
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 19 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Stroke, Intracranial Atherosclerotic Stenosis (ICAS)
Interventions: MRI; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 28
States / cities: Birmingham, Alabama • Aurora, Colorado • Hartford, Connecticut + 24 more

Conditions: CO-OP, Attention Control
Interventions: CO-OP, Attention Control; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Stroke
Interventions: Non-Interventional; Other
Lead sponsor: Valtari Bio; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 2
States / cities: Cincinnati, Ohio • Austin, Texas

Conditions: Ischemic Cerebrovascular Accident
Interventions: hyperbaric oxygen chamber; Other
Lead sponsor: John Davidson; Other
Eligibility: 50 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Chesterfield, Missouri

Conditions: Stroke
Interventions: Virtual Reality Mirror Therapy; Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Ischemic Stroke, Hypertension, Hyperlipidemias, Diabetes
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Aneurysm, Brain
Interventions: WAVE, as part of the SMART COIL System; Device
Lead sponsor: Penumbra Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 572 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 34
States / cities: Dothan, Alabama • Tucson, Arizona • La Mesa, California + 29 more

Conditions: Ischemic Stroke
Interventions: Reveal LINQ Insertable Cardiac Monitor; Device
Lead sponsor: Northwell Health; Other
Eligibility: 41 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: Manhasset, New York • New Hyde Park, New York

Conditions: Hemorrhagic Stroke, Intracerebral Hemorrhage (ICH)
Interventions: BAF312 solution, Matching Placebo for BAF312 solution, BAF312 tablet, Matching Placebo for BAF312 tablet; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 11
States / cities: Palo Alto, California • New Haven, Connecticut • Atlanta, Georgia + 7 more

Conditions: Stroke
Interventions: Split-belt treadmill training; Behavioral
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 20 Years and older
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Subarachnoid Hemorrhage, Aneurysmal
Interventions: Ptergyopalatine Fossa Block, Bupivacaine 0.25% Injectable Solution; Procedure · Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Search by objective public record fields.

VNS During Rehabilitation for Improved Upper Limb Motor Function After Stroke

Brain Stimulation-aided Stroke Rehabilitation: Neural Mechanisms of Recovery

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects

Transnasal Induction of Normothermia in Febrile Stroke Patients

Priming With tDCS: Expanding the Window of Recovery in Chronic Stroke

Treatment for Word Retrieval Impairments in Aphasia

Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage

Identifying Genes That May Increase the Risk for Heart Disease in African Americans

Chronic Kidney Disease (CKD) Platelet Study

Addressing Real-world Anticoagulant Management Issues in Stroke

Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)

Achieving Meaningful Clinical Benchmarks With Ekso Gait Training During Acute Stroke Inpatient Rehabilitation.

TMS and Exercise for Post-stroke Pain

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

CO-OPerative Training for Stroke Rehabilitation

Validation of Sensitivity and Specificity of a Multi-Omic Precision Diagnostic for Acute Stroke Evaluation

The Use of Hyperbaric Oxygen to Increase the Blood Supply in the Injured, But Still Alive Tissue, Around an Old Stroke

Virtual Reality Mirror Therapy for Stroke

Imaging the Pathogenesis of Cerebral Small Vessel Disease

Assessing the WAVE Extra Soft Coil in Intracranial Aneurysms and Comparing Imaging Modalities

Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke

Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH).

Gait Training in Post-Stroke Hemiparesis Hemiparesis

Pterygopalatine Fossa Block in Aneurysmal Subarachnoid Hemorrhage